Other than the devastation of ailing from cancer, cancer patients and their families are subjected to the unfriendly technique of treatment of cancer that is chemotherapy. Chemotherapy takes a toll on the human body. It is a technique that is brutal to the human body. Patients normally get seriously ill from the effects of chemotherapy. The treatment of cancer has evolved over the years and there are certain companies and individuals who have been at the forefront in the effort to ensure that the best method of cancer treatment is achieved.
The milestones that have been made so far are attributable to the selfless efforts of various individuals and companies. One such company is Seattle Genetics. Seattle Genetics is a leading biotechnology company located in Washington. The company was incorporated in 1998. The core mandate of the company is to provide quality care for cancer patients. This has been achieved through the efforts of the eight hundred employees of the company and through collaborations with other stakeholders. Seattle Genetics made a groundbreaking innovation in the area of cancer research with the release of Antibody-Drugs Conjugates. This cancer treatment technology seeks to specifically target the cancer cells only and not the good cells. It is an alternative to chemotherapy treatment because chemotherapy has been shown to have adverse effects even on the good cells. This takes a toll on the patient and it may result in further complications for the patient.
Seattle Genetics is also working with other line of products that are similar to ADCs. The release of the other products will further enhance the milestones that have been made in cancer research. Seattle Genetics is able to fund its activities due to the wide pool of resources that it has developed over the years.
Clay Siegall is the Co-founder of Seattle Genetics. He is also the Chief Executive Officer and the Chairman of the Board. He is a well-respected scientist and he holds various honorary positions. He is a great scientist and he has a great business acumen which has enabled him to lead Seattle Genetics to great scientific and business success.